Sonex Health and the Institute of Advanced Ultrasound Guided Procedures announce this milestone and host hands-on educational opportunities during the American Society for Surgery of the Hand 2023 Annual Meeting in Toronto
TORONTO, Oct. 3, 2023 /PRNewswire/ -- Sonex Health has announced from the American Society for Surgery of the Hand (ASSH) 2023 Annual Meeting in Toronto, that more than 20,000 patients have now been treated for carpal tunnel release (CTR) using UltraGuideCTR™ and real-time ultrasound guidance.
This milestone follows quickly on the heels of the company's close of a Series B financing, raising a total of $40 million. The proceeds from this investment will be used to significantly expand access to the company's groundbreaking commercially available devices that use ultrasound guidance to safely and effectively treat patients suffering from the debilitating pain caused by carpal tunnel syndrome (CTS) and trigger finger (TF) and allow those patients to quickly return to normal activities.
Throughout the ASSH conference, hand surgeons will have the opportunity to engage in hands-on, one-on-one demonstrations of CTR and TFR with ultrasound guidance through cadaver lab experiences at the Sonex Health booth (#939). These hands-on experiences will take place Wednesday, October 4, 4:30 p.m. - 7:30 p.m.; Thursday, October 5, 7:30 a.m. – 5 p.m.; and Friday, October 6, 8 a.m. - 4 p.m.
During the conference, Dr. Paul Paterson, Dr. Matthew Kirsch, Larry Miller, Ph.D., and Dr. Demetrio Aguila's e-poster presentation titled, "Rapid Return to Work after Carpal Tunnel Release with Ultrasound Guidance," will be on display as e-poster SPP0685.
In addition, Sonex Health will be hosting and participating in several other educational activities during ASSH, including:
To register or learn more, visit www.sonexhealth.com/assh-2023-annual-meeting.
ABOUT SONEX HEALTH
Sonex Health, Inc. is a leader in innovative ultrasound-guided therapies to treat common orthopedic conditions affecting the extremities, including entrapment neuropathies and tendinopathies. The company's proprietary devices allow surgeons to use real-time ultrasound guidance to visualize critical anatomy throughout procedures, thereby reducing both invasiveness and the cost of care, and enabling patients to return to their normal activities sooner. The company's first commercial device, UltraGuideCTR™, was designed to treat carpal tunnel syndrome and received FDA clearance in 2019. The company's second commercial device, UltraGuideTFR™ was designed to treat trigger finger, also known as stenosing tenosynovitis, and was released in 2022.
For information about Sonex Health, UltraGuideCTR, and UltraGuideTFR visit www.sonexhealth.com.
ABOUT THE INSTITUTE OF ADVANCED ULTRASOUND GUIDED PROCEDURES
Founded in 2018 to support the Sonex Health mission and clinical excellence, the Institute of Advanced Ultrasound Guided Procedures is focused on innovation supported by robust clinical research and world-class professional education and training that transforms the treatment experience for patients, providers, and payers. For more information about the Institute visit www.sonexhealth.com/educational-institute.
Media Contact:
Shelli Lissick
Bellmont Partners
shelli@bellmontpartners.com
651-276-6922
SOURCE Sonex Health